Market cap
$2,941 Mln
Revenue (TTM)
$4,649 Mln
P/E Ratio
--
P/B Ratio
2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-13 Mln
-
ROE
-0 %
-
ROCE
-2.1 %
-
Industry P/E
38.46
-
EV/EBITDA
19.7
-
Debt to Equity
0.7
-
Book Value
$--
-
EPS
$-0.1
-
Face value
--
-
Shares outstanding
140,123,008
7 Years Aggregate
CFO
$725.01 Mln
EBITDA
$256.99 Mln
Net Profit
$-796.16 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Covetrus (CVET)
| 5.1 | 0.6 | 1.3 | 8.0 | 22.9 | -- | -- |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
|
S&P Midcap 400#
| 13.1 | -0.1 | 0.9 | 17.0 | 12.3 | 6.5 | 9.1 |
|
Company
|
2021
|
2020
|
|---|---|---|
|
Covetrus (CVET)
| -30.5 | 117.7 |
|
S&P Midcap 400
| 23.2 | 11.8 |
|
BSE Sensex
| 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Covetrus (CVET)
|
21.0 | 2,941.2 | 4,649.0 | -13.0 | 0.0 | -0.9 | -- | 2.0 |
| 2.2 | 93.4 | 665.5 | -43.0 | -6.0 | -32.9 | -- | 0.5 | |
| 20.0 | 1,007.8 | 0.0 | -190.2 | -- | -41.7 | -- | 2.3 | |
| 17.6 | 814.1 | 175.5 | -702.0 | -549.2 | -- | -- | 9.5 |
Shareholding Pattern
View DetailsAbout Covetrus (CVET)
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment,... laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private. Read more
-
Pres, CEO & Director
Mr. Benjamin Wolin
-
Pres, CEO & Director
Mr. Benjamin Wolin
-
Headquarters
Portland, ME
-
Website
FAQs for Covetrus (CVET)
What is the current share price of Covetrus Inc (CVET) Today?
The share price of Covetrus Inc (CVET) is $20.99 (NASDAQ) as of 14-Oct-2022 09:30 EDT. Covetrus Inc (CVET) has given a return of 22.85% in the last 3 years.
What is the current PB & PE ratio of Covetrus Inc (CVET)?
Since, TTM earnings of Covetrus Inc (CVET) is negative, P/E ratio is not available.
The P/B ratio of Covetrus Inc (CVET) is 1.95 times as on 11-Nov-2022, a 21 discount to its peers’ median range of 2.47 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-50.66 |
1.81 |
2020 |
-178.49 |
2.21 |
2019 |
-1.39 |
1.12 |
2018 |
-- |
-- |
2017 |
-- |
-- |
What is the 52 Week High and Low of Covetrus Inc (CVET)?
The 52-week high and low of Covetrus Inc (CVET) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of Covetrus Inc (CVET)?
Covetrus Inc (CVET) has a market capitalisation of $ 2,941 Mln as on 11-Nov-2022. As per SEBI classification, it is a Mid Cap company.
Should I invest in Covetrus Inc (CVET)?
Before investing in Covetrus Inc (CVET), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.